NEW YORK – MDxHealth announced Monday that private equity firm MVM Partners has agreed to provide an equity investment of €12.7 million ($13.8 million) to the company.
MVM Partners will receive a subscription of nearly 20.2 million ordinary shares of MDxHealth at an issue price of €0.63 per share, a 5 percent discount to the 45-day volume weighted average price. MVM will become a 22 percent shareholder of the company after the transaction, which is expected to close on or around May 15.